palifosfamide-tris
IPM1004
Phase 1 small_molecule active
Quick answer
palifosfamide-tris for Malignancy is a Phase 1 program (small_molecule) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alaunos Therapeutics
- Indication
- Malignancy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active